<?xml version="1.0" encoding="UTF-8"?>
<p id="p0055">Currently, there is no specific and effective antiviral therapy available for COVID-19. However, most individuals with COVID-19 have a mild/asymptomatic or moderate course of the disease; in up to 5%â€“10% of individuals the course of the disease is severe and can lead to death in vulnerable sections of the community. The immediate need for effective drugs is crucial at this stage (
 <ext-link ext-link-type="uri" xlink:href="http://www.covidreference.com" id="intref0020" xmlns:xlink="http://www.w3.org/1999/xlink">www.covidreference.com</ext-link>) [
 <xref rid="bib34" ref-type="bibr">34</xref>].
</p>
